Table 4.
LLIN | n | Mortality % (95%CI) | n bloodfed | Abnormal | % Sterilized |
---|---|---|---|---|---|
Untreated | 45 | 2.22 (0.12–13.2) | 23 | 0 | 0 |
Olyset | 46 | 30.4 (18.2–45.9) | 19 | 0 | 0 |
Olyset Duo | 46 | 54.3 (39.2–68.8) | 10 | 6 | 60 |
PPF | 46 | 2.17 (0.11–13.0) | 35 | 35 | 100 |
LLIN | n | Mortality % (95%CI) | n bloodfed | Abnormal | % Sterilized |
---|---|---|---|---|---|
Untreated | 45 | 2.22 (0.12–13.2) | 23 | 0 | 0 |
Olyset | 46 | 30.4 (18.2–45.9) | 19 | 0 | 0 |
Olyset Duo | 46 | 54.3 (39.2–68.8) | 10 | 6 | 60 |
PPF | 46 | 2.17 (0.11–13.0) | 35 | 35 | 100 |